Back to results
US 10,537,588 B2Granted
Use of pimobendan for the reduction of heart size in mammals suffering from heart failure
OwnerJuergen Daemmgen, Olaf Joens +1inventors
InventorsJuergen Daemmgen, Olaf Joens, Rainer Kleemann
Life of this patent
Estimating the term…
Abstract
A phosphodiesterase type III (PDE III) inhibitor or Ca2+-sensitizing agent or a pharmaceutically acceptable derivative thereof is provided for the preparation of a medication for the reduction of the heart size of a patient suffering from heart failure.
Claims17
A method for treating a patient suffering from ISACHC (International Small Animal Cardiac Health Council) Classification Ib heart failure, the method comprising:
- administering to the patient a therapeutically effective amount of pimobendan or a pharmaceutically acceptable salt thereof;
- wherein the administration results in a reduction in the size of the patient's heart.
Dependencies are inferred from the claim text.